Navigation Links
Dr. Roger D. Weiss earns Hazelden's Dan Anderson Research Award
Date:3/21/2013

Hazelden's Butler Center for Research has awarded Roger D. Weiss, M.D., Chief of the Division of Alcohol and Drug Abuse at McLean Hospital in Massachusetts its latest "Dan Anderson Research Award" for his study examining the effectiveness of long-term buprenorphine maintenance accompanied by adjunctive counseling in the treatment of prescription opioid drug dependence.

This important award honors a single published article by a researcher who has advanced the scientific knowledge of addiction treatment and recovery.

Dr. Weiss earned the award for his study, "Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence," published in 2011 in the Archives of General Psychiatry. The study looked at over 650 individuals who were dependent on prescription opioids and sought outpatient treatment. All study participants received buprenorphine-naloxone and were randomly assigned to either standard medical management or standard medical management accompanied by opioid dependence counseling. In Phase I of the study, all participants received a two-week buprenorphine stabilization followed by a two-week taper. Participants who had an unfavorable outcome in Phase 1 were given an additional 12 weeks of buprenorphine maintenance followed by a four-week taper. In both phases, the study assessed opioid drug use during the first eight weeks after discontinuation of buprenorphine via self-report assessments and urinary drug screens.

"Abuse of prescription opioids is a significant public health and policy concern, with increasing rates of nonmedical use, emergency department visits, addiction treatment episodes, overdose deaths and costs related to these drugs in recent years" said Weiss. "The present findings raise an important question: what length of buprenorphine-naloxone treatment, if any, would lead to substantially better outcomes after a taper?"

Dr. Shelly F. Greenfield, director, Clinical and Health Services Research, Division of Alcohol and Drug Abuse at McLean Hospital nominated Dr. Weiss for the award, calling his paper "an example of Dr. Weiss' research career and its contribution to the advancement of scientific knowledge of addiction recovery."

The multisite study produced several interesting and noteworthy results. In Phase I, wherein participants received two weeks of buprenorphine followed by a two week taper, less than 7% of participants had favorable opioid use outcomes. In contrast, 49% of Phase II participants who received 12 weeks of buprenorphine followed by a four-week taper had positive opioid use outcomes while they were taking buprenorphine. However, success rates dropped substantially during the eight weeks following the end of the buprenorphine taper. The study also found that participants receiving standard medical management did not have better outcomes than patients receiving medical management and adjunctive opioid counseling, though Weiss and colleagues state that more frequent counseling over a longer period of time may have produced more positive results. They also stated that it is currently unclear whether longer term buprenorphine treatment before initiation of the taper would have produced better outcomes. Finally, the presence of chronic pain in some participants did not affect opioid use outcomes.

"Our Scientific Panel of Advisors was extremely impressed with the scientific rigor of this study, its two phase methodology, and the fact it examined extended buprenorphine maintenance," stated Dr. Audrey Klein, director of the Butler Center for Research at the Hazelden Foundation. "His current work on the use of long-term buprenorphine is innovative, timely, and essential given the current epidemic of prescription opioid addiction and increase in deaths related to opioid overdose."

Dr. Weiss will accept the award and a $2,000 honorarium from Hazelden later this year. The award is named for the late Dan Anderson, Ph.D., the former president of Hazelden and one of the major architects of the Minnesota Model, the interdisciplinary approach to addiction treatment that has been implemented worldwide.

Weiss' research was selected as the best from among several outstanding candidates by the Scientific Panel of the Butler Center for Research. The panel includes Klein; Valerie Slaymaker, Ph.D., Chief Academic Officer and Provost of the Hazelden Graduate School of Addiction Studies; Carlton Erickson, Ph.D., University of Texas-Austin; Lee Ann Kaskutas, Dr.PH, Alcohol Research Group, Emeryville, Calif.; Stephanie O'Malley, Ph.D., Yale University; Jon Morgenstern, Ph.D., National Center on Addiction and Substance Abuse, New York; John Finney, Ph.D., Center for Healthcare Evaluation, VA Palo Alto Health Care System; John F. Kelly, Ph.D., Massachusetts General Hospital, Psychiatry; and Constance Weisner, Ph.D., University of California-San Francisco.


'/>"/>

Contact: Christine Anderson
canderson@hazelden.org
651-213-4231
Hazelden
Source:Eurekalert  

Related medicine news :

1. Nobel laureate Roger Tsien, Ph.D., keynotes Cedars-Sinai nanomedicine conference March 15, 16
2. Rogers Athletic Company Donates Fitness Equipment to Eagle Village
3. Paul Larson OB/GYN Clinic Earns Top Rankings in a Recent Quality Report
4. Local Investment Advisor Earns Accredited Investment Fiduciary Designation
5. Lifespan research program earns national recognition
6. If Wife Earns More, Husbands Sexual Performance May Suffer: Study
7. HMHP and St. E’s Earns American Heart Association’s ‘Get With the Guidelines’ Gold Plus Award
8. Sound Shore Earns Joint Commission Dual Certification
9. Ride-Away’s VP of Finance and Insurance Earns AFIP Master Certification
10. OmniMD EHR Earns Surescripts White Coat of Quality for 2012
11. TrueShred Earns Esteemed 2012 Angie's List Super Service Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dr. Roger D. Weiss earns Hazelden's Dan Anderson Research Award
(Date:2/11/2016)... , ... February 11, 2016 , ... ... dermatology and women’s health, is pleased to announce the promotions of Allison Kelly ... sales team, Steve Catone to executive vice president of North American capital sales, ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... unparalleled clinical decision support technology, with highly adaptable algorithms, has been updated to ... patient has signs and symptoms consistent with Zikas and a travel history to ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... J.R. Garrett Esq. as General Counsel. Garrett will focus on contract negotiations, corporate ... audits, privacy and security law, and best practices in data breaches for the ...
(Date:2/11/2016)... ... ... Colorado spine surgeon, Donald Corenman, MD, DC has been selected ... 2016 . The list consists of spine surgeons across the country nominated by their ... the importance of clinical excellence; he has been awarded the Patient’s Choice Award, Compassionate ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance ... involvement program, introduces a new charity campaign to raise funds for Ronald McDonald ... accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... BURLINGAME, Calif. , Feb. 11, 2016  NOIT™ ... announced a special "Gift of Change" campaign to assist ... units. For every such unit sold between February 10, ... a unit to a needy family. The NOIT is ... helping non/limited-verbal autistic individuals develop language skills. ...
(Date:2/11/2016)... Ore. , Feb. 11, 2016 Wellpartner, ... announce the acquisition of SolutionsRx, a full-service 340B company ... Along with providing traditional contract pharmacy services, SolutionsRx also ... clients in navigating the complex 340B regulatory environment. ... --> James R. Love , CEO of ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions ... Transformational M&A achieved through NPS and Dyax acquisitions and the ... M&A achieved through NPS and Dyax acquisitions and the announced ... with most robust pipeline in Shire , s ... most robust pipeline in Shire , s history ...
Breaking Medicine Technology: